Ablation of phospholamban reverses slowed relaxation but not cardiac hypertrophy in mice lacking SERCA2a

被引：0
|
作者：
Louch, WE
Vangheluwe, P
Tjwa, M
Van Heyen, M
Kranias, E
Wuytack, F
Sipido, K
机构：
[1] Catholic Univ Louvain, B-3000 Louvain, Belgium
[2] Univ Cincinnati, Cincinnati, OH 45267 USA
来源：
BIOPHYSICAL JOURNAL | 2003年 / 84卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：98A / 98A
页数：1
相关论文
共 50 条
  • [1] Severe Cardiac Hypertrophy and Depressed Contractility in Transgenic Mice with Co-Overexpression of Calsequestrin and SERCA2a
    Kirchhefer, Uwe
    Baba, Hideo A.
    Jones, Larry R.
    Neumann, Joachim
    Schmitz, Wilhelm
    Mueller, Frank U.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 554A - 555A
  • [2] Ablation of phospholamban in SERCA2b/b mice reverses impairment of Ca2+ uptake into the sarcoplasmic reticulum despite reduction in SERCA levels
    Louch, W
    Vangheluwe, P
    Raeymaekers, L
    Kranias, E
    Wuytack, F
    Sipido, KR
    Leuven, KU
    EUROPEAN HEART JOURNAL, 2004, 25 : 118 - 118
  • [3] SERCA2a overexpression improves cardiac performance in diabetic mice
    Trost, SU
    Bluhm, WF
    Karlon, WJ
    Swanson, E
    Dillmann, WH
    CIRCULATION, 1998, 98 (17) : 140 - 140
  • [4] Immunofluorescence localization of SERCA2a and the phosphorylated forms of phospholamban in intact rat cardiac ventricular myocytes
    Drago, GA
    Colyer, J
    Lederer, WJ
    CARDIAC SARCOPLASMIC RETICULUM FUNCTION AND REGULATION OF CONTRACTILITY, 1998, 853 : 273 - 279
  • [5] Distinct effects of pressure and volume acute cardiac overload on SERCA2a and phospholamban gene expression
    Roncon-Albuquerque, R
    Henriques-Coelho, T
    Vasconcelos, M
    Teles, A
    Leite-Moreira, AF
    EUROPEAN HEART JOURNAL, 2003, 24 : 247 - 247
  • [6] Frequency-dependent acceleration of relaxation in mammalian heart:: a property not relying on phospholamban and SERCA2a phosphorylation
    Valverde, CA
    Mundiña-Weilenmann, C
    Said, M
    Ferrero, P
    Vittone, L
    Salas, M
    Palomeque, J
    Petroff, MV
    Mattiazzi, A
    JOURNAL OF PHYSIOLOGY-LONDON, 2005, 562 (03): : 801 - 813
  • [7] The phospholamban to SERCA2a ratio modifies the force-frequency relationship
    Bluhm, WF
    Meyer, M
    He, HP
    Glordano, FJ
    Lew, WYW
    Kranias, EG
    Dillmann, WH
    CIRCULATION, 1998, 98 (17) : 53 - 53
  • [8] A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban
    Kaneko, Manami
    Yamamoto, Hisato
    Sakai, Hiroki
    Kamada, Yusuke
    Tanaka, Toshiki
    Fujiwara, Shuji
    Yamamoto, Syunsuke
    Takahagi, Hiroki
    Igawa, Hideyuki
    Kasai, Shizuo
    Noda, Masakuni
    Inui, Makoto
    Nishimoto, Tomoyuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 814 : 1 - 8
  • [9] Binding site for residue 30 of phospholamban (PLB) on cardiac Ca pump (SERCA2a) localized.
    Jones, LR
    Cornea, RL
    Chen, ZH
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 265A - 265A
  • [10] USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes
    Ye, Bozhi
    Zhou, Hao
    Chen, Yanghao
    Luo, Wu
    Lin, Wante
    Zhao, Ying
    Han, Jibo
    Han, Xue
    Huang, Weijian
    Wu, Gaojun
    Wang, Xu
    Liang, Guang
    CIRCULATION RESEARCH, 2023, 132 (04) : 465 - 480
12345